Status:

UNKNOWN

Tolerability And Efficacy Of High Dose Escitalopram In The Treatment Of Patients Suffering From Schizophrenia And Obsessive-Compulsive Disorder (OCD) - An Open Label Study

Lead Sponsor:

BeerYaakov Mental Health Center

Conditions:

OCD

Schizophrenia

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The purpose of the study is to evaluate tolerability and efficacy of escitalopram (Cipralex) treatment in doses beyond 20mg (20-40 mg/d) in patients with OCD and schizophrenia, non responsive or parti...

Eligibility Criteria

Inclusion

  • All patients will be men and women over 18 years of age who meet DSM-IV criteria for schizophrenia/ schizoaffective disorder and OCD.
  • Previous to entering the study all patients should be stabilized on antipsychotic medication for at least 3 months.
  • Patients should score above 12 points on Yale Brown Obsessive Compulsive Scale (Y-BOCS) (Cut off point of Y-BOCS total score \> or =7 is the common practice in similar studies) (Kayahan et al 2005).

Exclusion

  • All patients who are under antidepressant treatment (including SSRIs and clomipramine).
  • In patients who were on clomipramine or SSRI in the past are included, at least 2 weeks must have been elapsed since stopping the medication.
  • In case the patient has received an antidepressant which is not an SSRI or clomipramine, there will be a washout period of one week before entering the study.
  • If the patient received a MAO-inhibitors there will be a washout period of at least 2 weeks except for fluoxetine for which a washout period of 5 weeks is required due to its long half-life.
  • Known contraindication for the use of citalopram or escitalopram.
  • Abnormal ECG findings at baseline
  • Unable to understand and give informed consent.

Key Trial Info

Start Date :

July 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2010

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT00708396

Start Date

July 1 2008

End Date

July 1 2010

Last Update

January 27 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Beer-Yaacov MHC

Beer-Yaacov, Israel, 70350

Tolerability And Efficacy Of High Dose Escitalopram In The Treatment Of Patients Suffering From Schizophrenia And Obsessive-Compulsive Disorder (OCD) - An Open Label Study | DecenTrialz